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Abstract
Objective Recently, the FCRL3 -169T[C (rs7528684)
single-nucleotide polymorphism (SNP) has been demon-
strated to be a risk factor of endometriosis related infer-
tility. We studied whether the FCRL -169T[C SNP can be
associated with endometriosis-related infertility in a sam-
ple of the Polish population
Methods Using PCR–RFLP analysis we genotyped 141
infertile women with endometriosis and 519 fertile women.
FCRL3 transcript levels were determined by reverse tran-
scription and real-time quantitative PCR analysis in CD19?
B cells from women with endometriosis-associated infer-
tility and fertile women
Results We found a significantly increased frequency of
the FCRL3 C/C genotype in women with endometriosis-
associated infertility than controls [OR = 1.681 (95 %
CI = 1.120–2.522, p = 0.0116, pcorr = 0.0348)]. There
was also a statistically increased frequency of the C/C and
C/T genotypes in patients compared with controls
[OR = 2.009 (95 % CI = 1.214–3.324, p = 0.0059,
pcorr = 0.0177)]. The p value of the v
2 test for the trend
observed for the FCRL3 -169T[C polymorphism was also
statistically significant (ptrend = 0.0012, pcorr = 0.0036).
We also found significantly increased FCRL3 transcript
levels in carriers of the FCRL3 -169 CC vs TT and CT vs
TT genotype both in women with endometriosis-related
infertility (p = 0.012; p = 0.015) and fertile women
(p = 0.017; p = 0.032)
Conclusions FCRL3 -169T[C polymorphism alters the
expression of FCRL3 and can be a risk factor of endome-
triosis-related infertility.
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Introduction
Endometriosis is a gynecological disorder that develops in
approximately 6–10 % of reproductive age women [1].
This disease is attributed to the presence of ectopic endo-
metrial tissue in the abdominal organs and the abdominal
cavity [1, 2]. Although endometriosis has been intensively
studied, the exact cause of this disorder and associated
infertility is still unclear [1–3]. Involvement of the genetic
background, environmental factors, and changes in the
endocrine and immune systems are recognized in the
development and persistence of endometriosis [1–3].
The growth of endometrium that implants outside the
uterine cavity in women with endometriosis can be explained
by two main findings. First, the endometriotic implants dis-
play activation of oncogenic pathways or increased activity
of estrogen action, as well as prostaglandins, cytokines, and
metalloproteinases supporting their survival [4]. Second, the
ability of endometrium implants to survive outside the uterus
may be linked to a defective immune system that is unable to
clear these endometrial implants [4, 5].
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It has been demonstrated that reduced natural killer cell
cytotoxicity and cytokines biosynthesized by peritoneal
macrophages may increase implantation and growth of
ectopic endometrial tissue [6–8]. There is also evidence
that B lymphocytes play a significant role in the patho-
genesis of endometriosis [9]. They produce autoantibodies,
which are commonly seen in various autoimmune diseases
[9]. This indicates that genetic factors that modulate the
function of B cells may be associated with endometriosis
and endometriosis-related infertility.
Recently, the FCRL3 gene, encoding Fc receptor-like 3
(FCRL3), was suggested as a novel autoimmune risk factor
[10]. FCRL3 is an orphan cell surface receptor presented
mainly in B lymphocytes of lymph nodes and germinal
centers [11]. The single-nucleotide polymorphism (SNP)
-169T[C (rs7528684), situated in the promoter region,
changes the expression of FCRL3 [10]. In addition to this
finding, Kochi et al. (2008) demonstrated the FCRL3 169C
gene variant effect on the inhibitory potential of B cell
receptor-mediated signaling that alters the activation
threshold and promotes tolerance breakdown in B cells
[11]. Recently, the FCRL3 -169T[C SNP was demon-
strated as a risk factor of endometriosis related infertility
[12]. Therefore, we studied whether the FCRL3 -169T[C
SNP may be associated with endometriosis-related infer-
tility in a sample of the Polish population.
Materials and methods
Patients and controls
Peripheral blood samples from women with endometriosis
and control women were obtained from the Gynecologic
and Obstetrical University Hospital, Division of Repro-
duction at Poznan University of Medical Sciences. The
studied women were allocated into one of two groups: 141
were primary infertility women with endometriosis and
519 women were used as the fertile controls (Table 1).
Inclusion criteria for infertile women with endometriosis
were regular menses, no anatomical changes in the repro-
ductive tract, no hormonal treatments, and a minimum of
1 year of infertility with a current desire for conception.
Exclusion criteria were male factor infertility, polycystic
ovary syndrome (PCOS), mechanical distortion of the
endometrial cavity by fibroids, and bilateral tubal occlu-
sion. All included patients with endometriosis had laparo-
scopic and histological diagnosis of endometriosis. The
stage of endometriosis was assessed according to the
revised classification of the American Society for Repro-
ductive Medicine (rASPM) [13].
The fertile women assigned to the control group were
examined for the cause of chronic pelvic pain without any
pelvic abnormalities determined by laparoscopy. The
controls were diagnosed as having varicose veins in the
pelvic floor but no signs of past or present inflammation.
Inclusion criteria for fertile control women were regular
menses, no anatomical changes in the reproductive tract, no
hormonal treatments, and at least one child born no more
than 1 year before laparoscopy (Table 1). Exclusion cri-
teria were diagnosis of past or present inflammation, pelvic
abnormalities, endometriotic lesions, PCOS, and bilateral
tubal occlusion. All included control women were laparo-
scopically examined due to chronic pelvic pain and sus-
pected endometriosis, pelvic floor varicose veins. Patients
and controls were matched by age and were all Caucasian
of Polish descent (Table 1). Written informed consent was
obtained from all participating individuals. The study
procedures were approved by the Local Ethical Committee
of Poznan University of Medical Sciences.
Genotyping
DNA was isolated from peripheral leucocytes using a
standard salting out procedure. Identification of the FCRL3
-169T[C (rs7528684) polymorphic variant was per-
formed by polymerase chain reaction-restriction fragment
length polymorphism (PCR–RFLP). PCR was conducted
employing primer pair 50CTGAACAGGAAAATAATAC
AAATGT 30and 50TGAAACAAAATAATGGGGTGGAA
30. The PCR-amplified fragments of FCRL3 that were
167 bp in length were isolated and digested with the
endonuclease BsmFI (50 GGGAC(N)10/30) New England
BioLabs (Ipswich, USA). The FCRL3 C allele was cleaved
into 119 and 48 bp fragments, whereas the FCRL3 T allele
remained uncut. DNA fragments were separated by elec-
trophoresis on 3 % agarose gel and visualized by ethidium
bromide staining. The FCRL3 -169T[C polymorphism
was confirmed by repeated PCR–RFLP for all samples.
Furthermore, 20 % of randomly selected samples were
confirmed by commercial sequencing analysis.




Age (years) 33 (21–38)a 33 (20–39)a
Parity NA 1 (1–4)a
Duration of infertility (years) 4 (1–8)a NA
RASRM (stage)b Stage I (n = 69) NA
Stage II (n = 72)
NA not applicable
Median a(Range), revised American Society for Reproductive Medi-
cine classification b(rASRM) [13]
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CD19? B cell isolation
A 5-ml blood sample from women with endometriosis
related infertility or controls was collected into tubes con-
taining EDTA. To obtain CD19? B cells from whole
peripheral blood, we used the positive biomagnetic sepa-
ration technique using Dynabeads CD19 Pan B,
Dynal Biotech (Oslo, Norway) according to the manufac-
turer’s instructions. Magnetic beads were detached by
DETACHaBEAD CD19, Dynal Biotech (Oslo, Norway)
using a polyclonal sheep anti-mouse-Fab antibody. Isolated
CD19? cells were washed twice at room temperature in
modified Eagle’s medium, followed by total RNA isolation.
Real-time quantitative PCR (RQ-PCR) analysis
of FCRL3 transcript level in CD19? B cells
Total RNA was isolated according to the method of
Chomczyn´ski and Sacchi [14]. RNAs samples were treated
with DNase I, quantified and reverse-transcribed (RT) into
cDNA. Quantitative analysis of FCRL3 cDNA was per-
formed by Light Cycler480 II Real-Time PCR System,
Roche Diagnostics GmbH (Mannheim, Germany), using
SYBR Green I as detection dye. FCRL3 cDNA was
quantified using the relative quantification method with a
calibrator. The calibrator was prepared as a cDNA mix
from all cDNA samples and consecutive dilutions were
used to create a standard curve as described in Relative
Quantification Manual Roche Diagnostics GmbH (Mann-
heim, Germany). For amplification, 1 ll of cDNA solution
was added to 9 ll of LightCycler 480 SYBR Green I
Master Mix Roche Diagnostics GmbH (Mannheim, Ger-
many) and primers. The quantity of FCRL3 transcript in
each sample was standardized by the porphobilinogen
deaminase (PBGD) transcript level. The PCR amplification
efficiency for target and reference genes was determined by
different standard curves created by consecutive dilutions
of the cDNA template mixture, as provided in Relative
Quantification Manual Roche Diagnostics GmbH (Mann-
heim, Germany). The FCRL3 cDNA 123 bp amplicon was
amplified employing the primer pair: (forward 50
GGTCACAGTTCCGGTGTCTC30) and (reverse 50 CAG
TACAGGATCGGGAAGGA30). The PBGD cDNA 160 bp
amplicon was amplified using the primer pair: (forward 50
GCC AAG GAC CAG GAC ATC 30) (reverse 50 TCA
GGT ACA GTT GCC CAT C 30). The FCRL3 mRNA
levels were expressed as multiples of these cDNA con-
centrations in the calibrator.
Statistical analysis
The distribution of genotypes in patients and controls was
examined for deviation from Hardy–Weinberg equilibrium.
Since the best inheritance model contribution of FCRL3 -
169T[C SNP to endometriosis-related infertility is unknown
in our population, the data were analyzed under recessive and
dominant models. In addition, to determine the polymor-
phism’s association with endometriosis-related infertility, the
additive genetic model was tested using Armitage’s test for
trend (ptrend). The differences in genotype frequencies
between cases and controls were determined using standard
Chi squared (v2), the Odds ratio (OR), and 95 % Confidence
intervals (95 % CI) were calculated and a p value\0.05 was
considered statistically significant. Power calculations for this
study were conducted using Quanto software (Gauderman
WJ, Morrison JM. QUANTO 1.2: A computer program for
power and sample size calculations for genetic-epidemiology
studies, URL: http://hydra.usc.edu/gxe, 2006). Statistical
analysis of FCRL3 transcript level comparison between CC
vs TT and CT vs TT genotype carriers was evaluated by
Mann–Whitney Rank Sum Test.
Results
Distribution of the FCRL3 -169T[C polymorphism
in women with endometriosis associated infertility
Genotype evaluation of the FCRL3 -169T[C polymor-
phism did not demonstrate significant aberration from the
Hardy–Weinberg equilibrium in the patient and control
groups.
We found an approximately 1.4-fold significantly
increased frequency of the FCRL3 C/C genotype in in
women with infertility-associated endometriosis over
the controls [OR = 1.681 (95 % CI = 1.120–2.522,
p = 0.0116, pcorr = 0.0348)]. There was also a signifi-
cantly increased frequency of the C/C and C/T genotypes
in patients compared with controls [OR = 2.009 (95 %
CI = 1.214–3.324, p = 0.0059, pcorr = 0.0177)] (Table 2).
The p value of the v2 test for the trend observed for the
FCRL3 -169T[C polymorphism was also statistically
significant (ptrend = 0.0012, pcorr = 0.0036).
A power analysis predicted sufficient power to detect an
association of the FCRL3 -169T[C polymorphism with a
genetic effect of 2.00 or more for the dominative model
and a genetic effect of 1.80 or more for the recessive model
(Table 3).
Effect of FCRL3 -169T[C polymorphism on FCRL3
transcript levels in CD19? B cells from fertile women
and women with endometriosis-related infertility
We observed significantly increased FCRL3 transcript levels
in the CD19? B cells from carriers of the FCRL3 -169 C
gene variant as compared with carriers of the FCRL3 -169
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TT genotype in fertile women. The median of FCRL3 tran-
script levels in B cells from fertile women with the CC
genotype was 1.263 (range 0.305–0.421) (p = 0.017), 1.060
(range 0.430–2.899) (p = 0.032) for the CT genotype, and
0.663 (range 0.301–1.349) for the TT genotype (Fig. 1a).
There were also significantly increased FCRL3 transcript
levels in the CD19? B cells from carriers of the FCRL3 -169
C gene variant as compared with carriers of the FCRL3 -169
TT genotype in women with endometriosis-related infertil-
ity. The median of FCRL3 transcript levels in B cells from
endometriosis women with the CC genotype was 1.017
(range 0.493–2.120) (p = 0.012), with the CT genotype was
0.951 (range 0.406–2.616) (p = 0.015), and with the TT
genotype was 0.485 (range 0.391–0.611) (Fig. 1b).
Discussion
Endometriosis is a complex disease accompanied by
changes in the expression of genes encoding proteins
affecting sex hormone activity, proteins involved in vas-
cular and tissue rebuilding, glucose homeostasis enzymes,
and inflammatory mediators [15]. Infertility is recognized
in 30 to 50 % of women with endometriosis [1–3]. This
disorder disturbs most stages of reproduction, including
granulosa cell steroidogenesis, folliculogenesis, ovulation,
fertilization, and blastocyst implantation [1, 16, 17].
There are several pieces of evidence that demonstrate
the involvement of an abnormal humoral immune response
in the infertility of women with endometriosis. In patients
with endometriosis, B cells have been shown to produce
autoantibodies recognizing phospholipids, histones, poly-
nucleotides, and even autoantibodies characteristic for
lupus [18, 19]. The presence in blood plasma of autoanti-
bodies against endometrial, ovarian, and laminin-1 tissues
may partially explain subfertility in women with endome-
triosis [20, 21]. Moreover, women with endometriosis
exhibit headaches, arthralgia, myalgia, fibromyalgia,
chronic fatigue syndrome, and other symptoms character-
istic for patients with autoimmune disease [22–24]. This
suggests common candidate genes that contribute to the
pathogenesis of autoimmunity and endometriosis [25].
We observed an association of the FCRL3 -169T[C
polymorphism with occurrence of endometriosis related
infertility. To date, the rs7528684 SNP has been recog-
nized as a genetic risk factor of endometriosis-related
infertility as well as idiopathic infertility in Brazilian
women [12, 26, 27].
The FCRL3 -169T[C polymorphism has also been
identified as a risk factor of various autoimmune diseases,
including rheumatoid arthritis, systemic lupus erythema-
tosus, Hashimoto thyroiditis, Graves’ disease, and biliary
cirrhosis [10, 28].
We also found significantly increased FCRL3 transcript
levels in the CD19? B cells from carriers of the FCRL3
-169T C gene variant as compared with carriers of the
FCRL3 -169 TT genotype both in women with endome-
triosis-related infertility and fertile women. To date, it has
Table 2 Association of the FCRL3 -169T[C (rs7528684) SNP with endometriosis-related infertility
Gene (rs no.) Allelesa MAFb Genotypesc ORrecessive (95 % CI);
p valued





FCRL3 (rs7528684) c/T 0.49 no 21/73/47 135/265/119 1.681 (1.120–2.522); 0.0116 2.009 (1.214–3.324); 0.0059 0.0012
% 15,52,33 26,51,23
a Uppercase denotes the more frequent allele in the control samples
b MAF, minor allele frequency calculated from the control samples
c The order of genotypes: DD/Dd/dd (d is the minor allele)
d Chi square analysis
e Cochran-Armitage trend test
Table 3 Power analysis
Model








Power calculations for this study were conducted using Quanto
software (Gauderman WJ, Morrison JM. QUANTO 1.2: A computer
program for power and sample size calculations for genetic-epide-
miology studies, URL: http://hydra.usc.edu/gxe, 2006). Power anal-
ysis was conducted with the following parameters: allele frequency
0.49, frequency of endometriosis associated infertility 0.03 in popu-
lation, significance level 0.05, two-sided
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been observed that the FCRL3 -169T[C SNP affects the
expression of FCRL3 by changing the affinity binding of
nuclear factor-kappa B (NF-jB) to its promoter. Kochi et al.
[10], using luciferase reporter gene analysis, demonstrated
the significantly increased transcriptional activity of the
disease-susceptible FCRL3 -169C gene variant as com-
pared with the non-disease-susceptible FCRL3 -169T gene
variant. Moreover, Gibson et al. [29] demonstrated that
venous blood CD19? B cells from normal donors, -169 CC
homozygotes, exhibited significantly higher levels of the
FCRL3 protein than B cells from TT homozygotes.
To date, the genetic risk factors for endometriosis-rela-
ted infertility have included the 17b-hydroxysteroid dehy-
drogenase type 1, ESR1, ESR2, and luteinizing hormone
beta-subunit genes [30–33]. Furthermore, polymorphisms
situated in FOXP, complement component 3, and lysyl
oxidase-like protein 4 genes have also been reported as
genetic factors which affect fertility in women with endo-
metriosis [27, 34].
Our study confirmed an association of the FCRL3
-169T[C polymorphism with endometriosis-related infer-
tility. Our genetic studies were conducted on a limited number
of infertile women with endometriosis; therefore, the role of
this polymorphism should be further studied in women with
idiopathic infertility and a larger and independent cohort of
women with endometriosis-related infertility.
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